secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cardio Diagnostics Holdings, Inc. (CDIO)
CIK:        0001870144
Form:       8-K
Filed at:   2022-10-31T23:59:59+00:00
Accession:  0001079973-22-001382
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 3.01, 1.01, 2.01, 5.02, 9.01, 4.01, 3.03, 5.01, 5.03, 5.06, 5.07, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardio Diagnostics completes SPAC merger with Mana Capital; begins trading as CDIO, CDIOW
--------------------------------------------------------------------------------

- Mana stockholders approved merger on Oct 25; Business Combination closed same day, Legacy Cardio becomes subsidiary.
- 6,465,452 Mana shares redeemed for $65.3M ($10.10/share); 9.5M shares outstanding post-closing.
- Legacy Cardio stockholders (72.8% ownership) received ~6.9M shares; Sponsor holds 17.1% (1.625M shares).
- Earnout up to 1M additional shares if stock price reaches $12.50-$20.00 targets over 4 years.
- Common stock and warrants now trade on Nasdaq under CDIO and CDIOW; lock-up on ~5.2M shares for 6 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870144/000107997322001382/0001079973-22-001382-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870144/000107997322001382/cdio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-22-001382

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer